Cargando…

A neural substrate of compulsive alcohol use

Alcohol intake remains controlled in a majority of users but becomes “compulsive,” i.e., continues despite adverse consequences, in a minority who develop alcohol addiction. Here, using a footshock-punished alcohol self-administration procedure, we screened a large population of outbred rats to iden...

Descripción completa

Detalles Bibliográficos
Autores principales: Domi, Esi, Xu, Li, Toivainen, Sanne, Nordeman, Anton, Gobbo, Francesco, Venniro, Marco, Shaham, Yavin, Messing, Robert O., Visser, Esther, van den Oever, Michel C., Holm, Lovisa, Barbier, Estelle, Augier, Eric, Heilig, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373126/
https://www.ncbi.nlm.nih.gov/pubmed/34407947
http://dx.doi.org/10.1126/sciadv.abg9045
Descripción
Sumario:Alcohol intake remains controlled in a majority of users but becomes “compulsive,” i.e., continues despite adverse consequences, in a minority who develop alcohol addiction. Here, using a footshock-punished alcohol self-administration procedure, we screened a large population of outbred rats to identify those showing compulsivity operationalized as punishment-resistant self-administration. Using unsupervised clustering, we found that this behavior emerged as a stable trait in a subpopulation of rats and was associated with activity of a brain network that included central nucleus of the amygdala (CeA). Activity of PKCδ(+) inhibitory neurons in the lateral subdivision of CeA (CeL) accounted for ~75% of variance in punishment-resistant alcohol taking. Activity-dependent tagging, followed by chemogenetic inhibition of neurons activated during punishment-resistant self-administration, suppressed alcohol taking, as did a virally mediated shRNA knockdown of PKCδ in CeA. These findings identify a previously unknown mechanism for a core element of alcohol addiction and point to a novel candidate therapeutic target.